GERN
Price
$1.15
Change
-$0.12 (-9.52%)
Updated
Jul 28, 04:59 PM (EDT)
Capitalization
732.46M
9 days until earnings call
LIANY
Price
$0.06
Change
+$0.01 (+20.00%)
Updated
Jul 25 closing price
Capitalization
6.44M
14 days until earnings call
Interact to see
Advertisement

GERN vs LIANY

Header iconGERN vs LIANY Comparison
Open Charts GERN vs LIANYBanner chart's image
Geron
Price$1.15
Change-$0.12 (-9.52%)
Volume$1.26M
Capitalization732.46M
LianBio
Price$0.06
Change+$0.01 (+20.00%)
Volume$19.84K
Capitalization6.44M
GERN vs LIANY Comparison Chart in %
Loading...
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIANY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GERN vs. LIANY commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GERN is a Buy and LIANY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 29, 2025
Stock price -- (GERN: $1.15 vs. LIANY: $0.06)
Brand notoriety: GERN and LIANY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GERN: 229% vs. LIANY: 107%
Market capitalization -- GERN: $732.46M vs. LIANY: $6.44M
GERN [@Biotechnology] is valued at $732.46M. LIANY’s [@Biotechnology] market capitalization is $6.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GERN’s FA Score shows that 0 FA rating(s) are green whileLIANY’s FA Score has 1 green FA rating(s).

  • GERN’s FA Score: 0 green, 5 red.
  • LIANY’s FA Score: 1 green, 4 red.
According to our system of comparison, LIANY is a better buy in the long-term than GERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GERN’s TA Score shows that 3 TA indicator(s) are bullish while LIANY’s TA Score has 5 bullish TA indicator(s).

  • GERN’s TA Score: 3 bullish, 5 bearish.
  • LIANY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LIANY is a better buy in the short-term than GERN.

Price Growth

GERN (@Biotechnology) experienced а -6.50% price change this week, while LIANY (@Biotechnology) price change was +9.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.28%. For the same industry, the average monthly price growth was +17.90%, and the average quarterly price growth was +45.83%.

Reported Earning Dates

GERN is expected to report earnings on Nov 06, 2025.

LIANY is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GERN($732M) has a higher market cap than LIANY($6.44M). GERN YTD gains are higher at: -67.514 vs. LIANY (-77.736). LIANY has higher annual earnings (EBITDA): -105.26M vs. GERN (-114.49M). LIANY has less debt than GERN: LIANY (2.84M) vs GERN (122M). GERN has higher revenues than LIANY: GERN (116M) vs LIANY (0).
GERNLIANYGERN / LIANY
Capitalization732M6.44M11,370%
EBITDA-114.49M-105.26M109%
Gain YTD-67.514-77.73687%
P/E RatioN/AN/A-
Revenue116M0-
Total Cash397MN/A-
Total Debt122M2.84M4,291%
FUNDAMENTALS RATINGS
GERN: Fundamental Ratings
GERN
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
76
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GERNLIANY
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
87%
Momentum
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 4 days ago
77%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
78%
Advances
ODDS (%)
Bullish Trend 6 days ago
74%
Bullish Trend 26 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 7 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
76%
Aroon
ODDS (%)
Bearish Trend 4 days ago
78%
Bullish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIANY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AGRFX118.63N/A
N/A
AB Growth A
FICGX13.14N/A
N/A
Cantor Fitzgerald Large Cap Fcs Cl A
ISTIX84.29N/A
N/A
Macquarie Science and Technology I
BMISX7.45N/A
N/A
BNY Mellon Income Stock C
GEMJX13.45N/A
N/A
Goldman Sachs Emerging Mkt Eq ex. ChnIns

LIANY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIANY has been closely correlated with SER. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if LIANY jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIANY
1D Price
Change %
LIANY100%
+3.51%
SER - LIANY
69%
Closely correlated
+5.83%
GERN - LIANY
53%
Loosely correlated
-8.73%
TRML - LIANY
28%
Poorly correlated
+14.37%
OTLK - LIANY
23%
Poorly correlated
-1.47%
MTNB - LIANY
21%
Poorly correlated
-0.01%
More